3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Myelodysplastic Syndromes
2
Anemia, Refractory, with Excess of Blasts
2
Recurrence
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Biphenotypic, Acute
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Interventions
Nivolumab
2
Ipilimumab
2
spartalizumab
1
poly ICLC
1
balstilimab
1
atezolizumab
1
Specimen Handling
1
Sorafenib
1
Irinotecan
1
DT2216
1
Cyclophosphamide
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fibrolamellar hepatocellular carcinoma
×
Antilymphocyte Serum
×
90 days
×
Clear all
No trials found.